|Who we work for
|Developers (pharmaceutical, diagnostic, medical device)
|What we do
|Analyzing and modeling early which impact can be expected on therapy outcome and cost.Testing the hypothesis with future decision makers and payers.
|Assessing healthcare alternatives (HTA / health technology assessment).
Considering stakeholder perspectives (e.g. patients / citizens)
Platform for early influence on new products and services.
Networking with peers across boarders.
Platform for addressing current topics in healthcare related decision making
|Defining the targets in the development.Identifying the path to the market.Value dossiers and value dossier reviews
|Setting priorities among the investment alternatives.
Education and training – tailored to the need of the recipients
(e.g. health economic and outcomes research methods – international health policy – decision support / prioritization – quality assessment)
|What the goal is
|… to improve the overall value balance of products and services in healthcare
By knowing and integrating the perspectives of our customers, we balance and mediate their perceptions of value – early and throughout product development.